Pharming Announces Initiation of Clinical Phase I/II Pre-Eclampsia Study

LEIDEN, Netherlands, June 11, 2019 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") today announces that, following receipt of the Dutch investigating ... Lees verder

Bron:

ANP Pers support